Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis.

Authors:
Russell R Kempker
Russell R Kempker
Emory University School of Medicine
United States
Aline B Barth
Aline B Barth
University of Florida
Sergo Vashakidze
Sergo Vashakidze
Emory University School of Medicine
United States
Ketino Nikolaishvili
Ketino Nikolaishvili
National Center for Tuberculosis and Lung Diseases
Nestani Tukvadze
Nestani Tukvadze
National Center for Tuberculosis and Lung Diseases
United States
Nino Bablishvili
Nino Bablishvili
National Center for Tuberculosis and Lung Diseases
Russia
Shota Gogishvili
Shota Gogishvili
Emory University School of Medicine
United States

Antimicrob Agents Chemother 2015 16;59(6):3149-55. Epub 2015 Mar 16.

Division of Infectious Diseases Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA Departments of Epidemiology and Global Health, Emory Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.

A better understanding of second-line drug (SLD) pharmacokinetics, including cavitary penetration, may help optimize SLD dosing. Patients with pulmonary multidrug-resistant tuberculosis (MDR-TB) undergoing adjunctive surgery were enrolled in Tbilisi, Georgia. Serum was obtained at 0, 1, 4, and 8 h and at the time of cavitary removal to measure levofloxacin concentrations. After surgery, microdialysis was performed using the ex vivo cavity, and levofloxacin concentrations in the collected dialysate fluid were measured. Noncompartmental analysis was performed, and a cavitary-to-serum levofloxacin concentration ratio was calculated. Twelve patients received levofloxacin for a median of 373 days before surgery (median dose, 11.8 mg/kg). The median levofloxacin concentration in serum (Cmax) was 6.5 μg/ml, and it was <2 μg/ml in 3 (25%) patients. Among 11 patients with complete data, the median cavitary concentration of levofloxacin was 4.36 μg/ml (range, 0.46 to 8.82). The median cavitary/serum levofloxacin ratio was 1.33 (range, 0.63 to 2.36), and 7 patients (64%) had a ratio of >1. There was a significant correlation between serum and cavitary concentrations (r = 0.71; P = 0.01). Levofloxacin had excellent penetration into chronic cavitary TB lesions, and there was a good correlation between serum and cavitary concentrations. Optimizing serum concentrations will help ensure optimal cavitary concentrations of levofloxacin, which may enhance treatment outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.00379-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432208PMC

Still can't find the full text of the article?

Let us try to send a request to the authors directly.
February 2016
37 Reads

Publication Analysis

Top Keywords

cavitary concentrations
12
levofloxacin concentration
8
multidrug-resistant tuberculosis
8
levofloxacin concentrations
8
serum cavitary
8
cavitary penetration
8
levofloxacin
8
correlation serum
8
cavitary
7
concentrations
6
serum
5
vivo cavity
4
performed vivo
4
cavity levofloxacin
4
received levofloxacin
4
patients received
4
levofloxacin median
4
median 373
4
median dose
4
surgery median
4

Similar Publications